Predictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age

EPMA Journal

Volumn 4, Issue 1, 2013, Pages

  Goncharenko, Vadym M ^a   Beniuk, Vasyl A ^b   Kalenska, Olga V ^a   Demchenko, Olga M ^c   Spivak, Mykola Ya ^c,d   Bubnov, Rostyslav V ^a,d  

^a Clinical Hospital Pheophania of State Affairs Department   (Ukraine)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c JSC SPC 'DiaprofMed'   (Ukraine)

^d ZABOLOTNY INSTITUTE OF MICROBIOLOGY AND VIROLOGY   (Ukraine)

Author keywords

Endometrial hyperplasia; Endometrial receptors; Endoscopic treatment; Fertile age women; Hysteroresection; Personalized medicine; Predictive; Preventive; Sonoelastography; Transvaginal ultrasonography; Women s health

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ABLATION THERAPY; ADULT; ALGORITHM; ARTICLE; CLINICAL EXAMINATION; COMORBIDITY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ECHOGRAPHY; ELASTOGRAPHY; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ENDOSCOPIC SURGERY; FEMALE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; HYSTERORESECTOSCOPY; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO FERTILIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARIECTOMY; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; RELAPSE; SENSITIVITY AND SPECIFICITY; STROMA; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UKRAINIAN (PEOPLE);

EID: 84927770502     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/1878-5085-4-24     Document Type: Article

References (78)

1. Golubnitschaja O, Costigliola V, EPMA: General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European association for predictive, preventive and personalised medicine. EPMA J 2012, 3:14.
2. Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH: Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J 2013, 4(1):6. doi:10.1186/1878-5085-4-6.
3. Benyuk VA, Kurochka VV, Vynyarskyi YM, Goncharenko VM: Diagnostic algorithm endometrial pathology using hysteroscopy in reproductive age women. Women Health (ZdorovyaZhinky) 2009, 6(42):54–56.
4. Manukhin IB, Tumilovich LG, Gevorgyan MA: Clinical Lectures on Gynecological Endocrinology. GEOTAR-Media: Moscow; 2001 (in Russian).
5. Zaporozhan VN, Tatarchuk TF, Dubinina VG, Kosey NV: Diagnosis and treatment of endometrial hyperplastic processes. Reprod Endocrinol 2012, 1(3):5–12.
6. Nicolaije KA, Ezendam NP, Vos MC, Boll D, Pijnenborg JM, Kruitwagen RF, Lybeert ML, van de Poll-Franse LV: Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry. Gynecol Oncol 2013, 129(2):324–331.
7. Giordano G, Gnetti L, Merisio C, Melpignano M: Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas 2007, 56(2):190–197.
8. Tatarchuk TF: Principles of use of progestogens in gynecology, DSc. dissertation thesis. Kyiv National Medical University: Department of Histology and Embryology; 2001.
9. Fujishita A, Nakane PK, Koji T, Masuzaki H, Chavez RO, Yamabe T, Ishimaru T: Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study. Fertil Steril 1997, 67(5):856–864.
10. Gregory CW, Wilson EM, Apparao KB, Lininger RA, Meyer WR, Kowalik A, Fritz MA, Lessey BA: Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 2002, 87(6):2960–2966.
11. Slayden OD, Brenner RM: Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists. Arch Histol Cytol 2004, 67(5):393–409.
12. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, Alberts D, Curtin J: Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. Cancer 2006, 106:812–819.
13. Rakha E, Wong SC, Soomro I, Chaudry Z, Sharma A, Deen S, Chan S, Abu J, Nunns D, Williamson K, McGregor A, Hammond R, Brown L: Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature. Am J Surg Pathol 2012, 36(11):1683–1690.
14. Starczewski A, Brodowska A, Strojny K, Puchalski A, Mieczkowska E, Szydlowska I: The value of ultrasonography in diagnosis of atypical endometrial hyperplasia in postmenopausal women. Przegl Lek 2005, 62(4):227–229.
15. Hecht JL, Mutter GL: Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006, 24(29):4783–4791.
16. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW: Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol 2000, 13(4):379–388.
17. Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA: p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol 1996, 61(2):167–174.
18. Maia H, Maltez A, Fahel P, Athayde C, Coutinho E: Detection of testosterone and estrogen receptors in the postmenopausal endometrium. Maturitas 2001, 38(2):179–188.
19. Bartosch C, Manuel Lopes J, Oliva E: Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features. Adv Anat Pathol 2011, 18(6):415–437.
20. Kommoss F, Karck U, Prömpeler H, Pfisterer J, Kirkpatrick CJ: Steroid receptor expression in endometria from women treated with tamoxifen. Gynecol Oncol 1998, 70(2):188–191.
21. Mutter GL, Ince TA, Baak JP, Kust GA, Zhou XP, Eng C: Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 2001, 61(11):4311–4314.
22. Kokawa K, Shikone T, Nakano R: Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996, 81:4144–4147.
23. Tao X-J, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, Tilly JL, Isaacson KB: Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin EndocrinolMetab 1997, 82:2738–2746.
24. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456–1462.
25. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80:879–886.
26. Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W: Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol 2000, 79(2):169–176.
27. Wang S, Pudney J, Song J, Mor G, Schwartz PE, Zheng W: Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia–precursor of endometrial cancer. Gynecol Oncol 2003, 88(2):108–117.
28. Bozdoğan O, Atasoy P, Erekul S, Bozdoğan N, Bayram M: Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium. Int J Gynecol Pathol 2002, 21(4):375–382.
29. Atasoy P, Bozdoğan O, Erekul S, Bozdoğan N, Bayram M: Fas-mediated pathway and apoptosis in normal, hyperplastic, and neoplastic endometrium. GynecolOncol 2003, 91(2):309–317.
30. Morsi HM, Leers MP, Radespiel-Tröger M, Björklund V, Kabarity HE, Nap M, Jäger W: Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry. Gynecol Oncol 2000, 77(1):11–17.
31. Gargett CE: Uterine stem cells: what is the evidence? Hum Reprod Update 2007, 13(1):87–101.
32. Mittal K, Schwartz L, Goswami S, Demopoulos R: Estrogen and progesterone receptor expression in endometrial polyps. Int J Gynecol Pathol 1996, 15(4):345–348.
33. Maia H, Maltez A, Studart E, Athayde C: Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle. BJOG 2004, 111(11):1242–1247.
34. Lopes RG, Baracat EC, de Albuquerque Neto LC, Ramos JF, Yatabe S, Depesr DB, Lippi UG: Analysis of estrogen- and progesterone-receptor expression in endometrial polyps. J Minim Invasive Gynecol 2007, 14(3):300–303.
35. Peng X, Li T, Xia E, Xia C, Liu Y, Yu D: A comparison of oestrogen receptor and progesterone receptor expression in endometrial polyps and endometrium of premenopausal women. J Obstet Gynaecol 2009, 29(4):340–346.
36. Maia H Jr, Barbosa IC, Marques D, Coutinho EM: Hysteroscopy and transvaginal sonography in women receiving hormone replacement therapy. J Am Assoc Gynecol Laparosc 1997, 4:13–18.
37. Maia H, Maltez A, Studard E, Athayde C, Coutinho EM: Effect of previous hormone replacement therapy on endometrial polyps during menopause. Gynecol Endocrinol 2004, 18:299–304.
38. Vereide AB, Kaino T, Sager G, Ørbo A: Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol 2005, 97(3):740–750.
39. Taylor LJ, Jackson TL, Reid JG, Duffy SRG: The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG 2003, 110:794–798.
40. Thijs I, Neven P, Van Hooff I, Tonglet R, Van Belle Y, De Muylder X, Vanderick G: Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. Eur J Cancer 2000, 36:108–109.
41. Hata H, Humano M, Watanabe J, Kuramoto H: Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells. Oncology 1998, 55(Suppl 1):35–44.
42. Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, Kandiloglu AR, Caglar H, Fraser IS: Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 2006, 61:24–28.
43. Maia H, Maltez A, Athayde C, Coutinho EM: Proliferation profile of endometrial polyps in post-menopausal women. Maturitas 2001, 40:273–281.
44. Maia H, Maltez A, Calmon LC, Oliveira M: Histopathology and steroid receptors in endometrial polyps of postmenopausal patients under hormone-replacement therapy. Gynaecol Endosc 1998, 7(5):267–272.
45. Davidson KG, Dubinsky TJ: Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin North Am 2003, 41(4):769–780.
46. Langer RD, Pierce JJ, O'Hanlan KA, Johnson SR, Espeland MA, Trabal JF, Barnabei VM, Merino MJ, Scully RE: Transvaginal ultrasonography has a poor positive predictive value but a high negative predictive value for detecting serious endometrial disease in asymptomatic postmenopausal women. N Engl J Med 1997, 337:1792–1798.
47. Lin MC, Gosink BB, Wolf SI, Feldesman MR, Stuenkel CA, Braly PS, Pretorius DH: Endometrial thickness after menopause: effect of hormone replacement. Radiology 1991, 180:427–432.
48. Malpani A, Singer J, Wolverson MK, Merenda G: Endometrial hyperplasia: value of endometrial thickness in ultrasonographic diagnosis and clinical significance. J Clin Ultrasound 1990, 18:173–177.
49. Smith P, Bakos O, Heimer G, Ulmsten U: Transvaginal ultrasound for identifying endometrial abnormality. Acta Obstet Gynecol Scand 1991, 70:591–594.
50. Varner RE, Sparks JM, Cameron CD, Roberts LL, Soong SJ: Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 1991, 78:195–199.
51. Granberg S, Wikland M, Karlsson B, Norstrom A, Friberg LG: Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 1991, 164:47–52.
52. Karlsson B, Granberg S, Wikland M, Ylöstalo P, Torvid K, Marsal K, Valentin L: Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding–a Nordic multicenter study. Am J Obstet Gynecol 1995, 172(5):1488–1494.
53. Fleischer AC, Wheeler JE, Lindsay I, Hendrix SL, Grabill S, Kravitz B, MacDonald B: An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001, 184:70–74.
54. Goldstein RB, Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, Fleischer AC, Goldstein SR, Hunt RB, Kurman RJ, Kurtz AB, Laing FC, Parsons AK, Smith-Bindman R, Walker J: Evaluation of the woman with postmenopausal bleeding: society of radiologists in ultrasound-sponsored consensus conference statement. J UltrasoundMed 2001, 20(10):1025–1036.
55. Persadie RJ: Ultrasonographic assessment of endometrial thickness: a review. J Obstet Gynaecol Can 2002, 24(2):131–136.
56. McFarlin BL: Ultrasound assessment of the endometrium for irregular vaginal bleeding. J Midwifery Womens Health 2006, 51(6):440–449.
57. Dubinsky TJ: Value of sonography in the diagnosis of abnormal vaginal bleeding. J Clin Ultrasound 2004, 32(7):348–353.
58. Tahir MM, Bigrigg MA, Browning JJ, Brookes ST, Smith PA: A randomised controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with inpatient hysteroscopy and curettage. Br J Obstet Gynaecol 1999, 106(12):1259–1264.
59. Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X: Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 1991, 13:111–134.
60. Preis K, Zielinska K, Swiatkowska-Freund M, Wydra D, Kobierski J: The role of elastography in the differential diagnosis of endometrial pathologies– preliminary report. Ginekol Pol 2011, 82(7):494–497.
61. Mukhomor OI, Bubnov RV: Sonoelastography for Prediction Outcome of Aspiration Treatment under Ultrasound Guidance of Ovarian Cystic Lesions. In Proceeding of EFSUMB Annual Meeting EUROSON, Abstracts Book. Madrid: Tilesa Kenes; 2012:227.
62. Bubnov RV: Method of integrated three-dimensional modeling of biomedical objects. Patent Ukraine 2011, 61:777. IPC A61B 8/08, issued 25.07.2011 (Bull. N 14).
63. Pilecki Z, Hrazdira L, Pilecki G, Bubnow R: Puncture techniques in ultrasonography. J Ultrasonography (Ultrasonografia) 2011, 45:38–45. Polish.
64. Oldenburg CS, Boll D, Nicolaije KA, Vos MC, Pijnenborg JM, Coebergh JW, Beijer S, van de Poll-Franse LV, Ezendam NP: The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based PROFILES registry. Gynecol Oncol 2013, 129(1):216–221.
65. Shapira N: Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. EPMA J 2013, 4:1.
66. Cebioglu M, Schild HH, Golubnitschaja O: Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J 2010, 1(1):130–137.
67. Popescu NC, Zimonjic DB: Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 2002, 6:151–159. doi:10.1111/j.1582- 4934.2002.tb00183.x.
68. Debald M, Yeghiazaryan K, Cebioglu M, Kuhn W, Schild HH, Golubnitschaja O: ‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention. EPMA J 2013, 4:22.
69. Bubnov RV: Evidence-based pain management: is the concept of integrative medicine applicable? EPMA J 2012, 3:13.
70. Spivak NYA, Shepel EA, Zholobak NM, Shcherbakov AB, Antonovitch GV, Yanchiy RI, Ivanov VK, Tretyakov YUD: Ceria nanoparticles boost activity of aged murine oocytes nano biomedicine and engineering. Nano Biomed. Eng 2013, 4(4):188–194.
71. Spivak MY, Bubnov RV, Yemets IM, Lazarenko LM, Tymoshok NO, Ulberg ZR: Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology. EPMA J 2013, 4(1):20.
72. Bubnov RV, Melnyk IM: Question of choice, decision making in diagnostic imaging and intervention mistake prediction: mathematical modeling approach. EPMA J 2011, 2(Suppl 1):186.
73. Melnyk IM, Bubnov RV: Choice of diagnostic decision making in medicine and intervention mistake prediction using mathematical models. Int J Inf Models Anal 2012, 1(1):78–83.
74. Melnik IM: Genetic algorithm for solving the problem of an optimum regression model construction as a discrete optimization problem. J Autom Inform Sci 2008, 40(6):60–71.
75. Bubnov RV, Melnyk IM: The methods of fractal analysis of diagnostic images Initial clinical experience. Lik Sprava 2011, 3–4:108–113.
76. Toporova OK, Irodov DM, Bubnov RV, Kholodkova OL, Gulko TP, Ruban TP, Morgunov PV, Kordium VA: Intrahepatic ultrasound-mediated gene delivery. J Hepatol 2013, 58:S119.
77. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74–108.
78. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M: Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378(9793):815–825.